TCL Archive Mytomycin C, RT Improve Head & Neck Results, Sartorelli Reports; Other AACR, ASCO Lectures June 5, 1987
TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive Facility Needs Panel Recommends $4.5-3 billion, Seven Year Program To Be Run By NIGMS Or DRR March 4, 1988
TCL Archive In Brief: NCI Contract Plans Shaping Up As RFP “Season” Approaches; L-B Profit Told September 13, 1974
